FDA names companies domestic drug manufacturing pilot participants to enhance early regulatory engagement and streamline review processes.
FDA revamps peptide panel by appointing wellness clinic physicians to advise on pharmacy compounding of seven peptides, including BPC-157 and TB-500.
MK-Ultra ran from 1953 to 1973 amid fears the Soviet Union and China were brainwashing prisoners during the Cold War.